Most provider groups will read the 2027 Medicare Physician Fee Schedule final rule as a Medicare story. It isn't. If a meaningful share of your commercial and Medicare Advantage contracts pay "a percentage of Medicare," the final rule is also a repricing event for those contracts, and it happens automatically, usually without a single email from the payer.
As of this week, CMS is expected to release the final rule "in the coming days," according to Medical Economics (Oct. 29, 2026). Before it lands, it's worth knowing exactly how your fee schedules are tied to it. Here is how I'd approach it, having built these escalator clauses from the payer side and negotiated against them from the provider side.
What CMS proposed for 2027
The CY 2027 proposed rule would lower the conversion factor for most clinicians. Per AHA's summary, the conversion factor would fall 1.68% for clinicians who are not qualifying APM participants and 1.19% for those who are. Medical Economics, reporting on MGMA's comments, puts those at $32.84 and $33.17 respectively.
The main driver is not a new cut so much as an expiring bump: the one-year 2.5% increase in effect for 2026 does not carry into 2027. Small statutory updates (0.75% for qualifying APM participants, 0.25% for everyone else) and a 0.53% adjustment tied to work RVU changes offset part of it.
Two other proposals matter for contract math:
- Same-day E/M with procedures. CMS proposed paying the highest-value service in full and reducing a separately identifiable same-day office visit to 50% (or 25% under an alternative), according to MGMA as reported by Medical Economics.
- G2211 changes. The same report says CMS would replace the roughly $16 G2211 add-on with modifiers that raise payment 16%, or 32% for MSSP or LEAD clinicians.
These are proposals. The final rule can and often does differ, so treat every number above as a placeholder until CMS publishes.
Why a Medicare rule reprices your commercial contracts
Many commercial and Medicare Advantage agreements don't list a dollar amount for each code. They say something like "125% of the current Medicare fee schedule for the applicable locality." That one sentence imports the entire RBRVS machinery into your contract: the conversion factor, RVU revisions, budget neutrality adjustments and, depending on the wording, CMS payment policies like multiple-procedure and same-day reductions.
When I sat on the payer side, these clauses were attractive for a simple reason: they keep the fee schedule current without anyone having to renegotiate it. That is also why they cut both ways. When Medicare goes up, you ride it. When Medicare goes down, as the proposed 2027 conversion factor would, your commercial rates follow, and your "multiplier" looks unchanged on paper.
The economists are not optimistic about the long-run trend either. Arizona State economist Jonathan Ketcham told Medical Economics that if the proposed changes are finalized, "we will be fully 35% in real reimbursement rates below where we were in 2016." A contract pegged to that baseline inherits that trajectory.
Five clauses to pull before the final rule drops
Every payer writes these differently. Before January, pull each Medicare-referenced agreement and answer five questions:
- Which year's Medicare? "Current year" means you take the 2027 change on Jan. 1 (or whenever the payer loads it). A fixed year, such as "the 2025 Medicare fee schedule," means you're insulated, but also frozen. Know which one you have.
- When does the payer update? Look for language on implementation timing. Some contracts update on the CMS effective date, others "within 90 days" or at the payer's next system load. Lag periods determine how long you're paid on the old rates, and whether the payer reprocesses claims afterward.
- Is there a floor? A "not less than" clause, or a provision that holds the prior-year rate when Medicare decreases, is the single most valuable protection in a Medicare-pegged contract. Most groups don't have one.
- Does the contract adopt CMS payment policy, or just CMS rates? If the agreement says the payer follows "Medicare reimbursement methodologies," a finalized same-day E/M reduction could flow straight into your commercial payments. If it references the fee schedule amounts only, you may have an argument that it doesn't.
- What happens to codes Medicare changes or deletes? If G2211 is replaced by modifiers, check how your contract handles new, deleted or modified codes. Many default to a payer-set "gap fill" or a percentage of billed charges, which may or may not be favorable.
How to benchmark the impact in dollars
Clause review tells you whether the rule hits you. Benchmarking tells you how much. The practical sequence:
- Start with your top codes by volume and revenue for each Medicare-referenced payer. For most groups, a few dozen CPT codes drive the majority of professional revenue.
- Model 2026 versus final 2027 allowed amounts using your locality and each contract's multiplier, once the final rule and RVU files are published.
- Multiply by your actual utilization to get a dollar impact per payer, not a percentage. "1.68%" doesn't move a negotiation; "$67,000 a year on Payer A" does. For scale: a group collecting $4 million a year from a payer whose rates track the Medicare conversion factor would lose about that much if the proposed 1.68% cut is finalized as is, before any code-level RVU changes.
- Compare against market rates. Payer transparency files now make it possible to see where your negotiated rates sit relative to peers for the same codes and market. If a Medicare-pegged contract was already below market, the 2027 change widens the gap.
- Check the payments, not just the contract. After the payer loads 2027 rates, compare actual allowed amounts to what the contract says you should be paid. Load errors and lag periods are where underpayments live.
What provider groups should do this quarter
The window between the final rule and Jan. 1 is short. A practical plan:
- This week: build an inventory of every agreement that references Medicare rates, with the multiplier, year reference, update timing and floor language for each.
- When the final rule publishes: re-run the numbers on your top codes and size the dollar impact by payer. Flag any contract where the impact is material and there is no floor.
- Before renewals: use that analysis to open conversations. The strongest asks are usually structural, not just a higher multiplier: a floor on Medicare decreases, a fixed base year, or carve-outs for codes affected by policy changes like the same-day E/M reduction.
- After Jan. 1: audit early 2027 remittances against expected allowed amounts so load errors get caught in weeks, not quarters.
Early in my time on the payer side, I sat across from a group whose renewal ask wasn't a higher multiplier. It was a floor: their rates could never drop below the prior year's schedule, even if Medicare did. At the time it looked like a small concession, so we gave it. In the years Medicare went down, theirs were the rates that didn't move, while groups that had pushed for a bigger multiplier and no floor quietly lost ground. I think about that every time I review a Medicare-pegged contract now. The clause that costs a payer little today is often the one that protects you most when the conversion factor turns.
Where viperOS fits
This is exactly the workflow we built viperOS to handle: pulling Medicare-referenced terms out of your contracts, benchmarking your fee schedules against market rates, and showing the dollar impact of a rule change by payer, so your team walks into renewals with numbers instead of instincts. It's the same playbook Carenodes has run for provider groups for years, productized.
If you want to see where your fee schedules stand before the 2027 rule takes effect, try the ROI calculator on the Viper website.